As per this study the Global Implantable Cardiac Monitor Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2027 with a CAGR of XX%.
The implantable cardiac monitor is the small implantable diagnostic device that monitors and records the electrolytic activity of the heart. It is also known as the implantable loop recorder. It is placed under the skin of the upper chest through a procedure that allows transmitting of the data regarding heart rhythm remotely. It is an effective diagnostic tool for the patient suffering from fainting, recurrent palpitation, dizziness, and other related issues.
The rise in cases suffering from atrial fibrillation, falling, epilepsy and other related medical conditions with rising awareness regarding symptoms and treatments of arrhythmia are driving the market growth. Higher longevity of these devices is another prominent factor boosting the adoption of implantable cardiac monitors. In addition, small size, easy to implant, accurate reading, and continuous monitoring is some of the factors propelling market growth. Despite this, the high cost of these devices is likely to curb the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of implantable cardiac monitor.
The broad implantable cardiac monitor market has been sub-grouped into indication and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Cardiac Arrhythmias
- Atrial Fibrillation
- Epilepsy & Unexplained Falls
- Cardiac Centers & Clinics
- Ambulatory Surgical Centers (ASCs)
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for implantable cardiac monitor in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Implantable Cardiac Monitor Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the implantable cardiac monitor market include Abbott Laboratories, Biotronik Se & Co. Kg, Boston Scientific Corporation, Edwards Life Science Corporation, GE Healthcare (A Healthcare Division Of GE Company), Koninklijke Philips N.V. (Philips Healthcare), Livanova Plc (Sorin), Medtronic Plc, Nihon Kohden Corporation, and Phoenix Heart Pllc among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.